Refine Your Results

Click below to filter your search results

"Gynecologic Cancers"Undo
"Medications or Drugs"Undo
Return to List
Results 1–2 of 2
Title Date
1.

Tamoxifen and Uterine Cancer

Number 336

(Reaffirmed 2008, Replaces No. 232, April 2000)

ABSTRACT: Tamoxifen may be associated with endometrial proliferation, hyperplasia, polyp formation, invasive carcinoma, and uterine sarcoma. Any symptoms of endometrial hyperplasia or cancer reported...

June 2006

PDF Format
2.

Aromatase Inhibitors in Gynecologic Practice

Number 412

(Reaffirmed 2012)

ABSTRACT: Aromatase inhibitors appear to be effective as an adjuvant treatment for early-stage and late-stage breast cancer. Their role in chemoprevention of breast cancer in high-risk patients remai...

August 2008

PDF Format